Science · 1988 · 157 citations · 10 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAlpha-particle TherapyCancer ImmunotherapyImmunotherapy For Solid TumorsTargeted Radionuclide TherapyTumor-associated AntigensAntibody-radioisotope ConjugatesCytotoxicity AssaysEnergy TransferImmunogenicity Of Tumor AntigensIntraperitoneal AdministrationLinear Energy Transfer EffectsT Cell CytotoxicityT Cell-target Cell Interactions
Alpha particles are energetic short‑range ions whose high linear energy transfer causes extreme cytotoxicity. The authors prepared a bismuth‑212‑labeled IgM radioimmunoconjugate that targets the Thy 1.2 antigen on murine T cells. The conjugate selectively killed Thy 1.2‑positive EL‑4 tumor cells in vitro, with ~3 molecules per cell eliminating DNA synthesis, and cured ascites in mice after 150 µCi intraperitoneal injection, suggesting therapeutic promise.
Alpha particles are energetic short-range ions whose higher linear energy transfer produces extreme cytotoxicity. An α-particle-emitting radioimmunoconjugate consisting of a bismuth-212-labeled monoclonal immunoglobulin M specific for the murine T cell/neuroectodermal surface antigen Thy 1.2 was prepared. Analysis in vitro showed that the radioimmunoconjugate was selectively cytotoxic to a Thy 1.2 + EL-4 murine tumor cell line. Approximately three bismuth-212-labeled immunoconjugates per target cell reduced the uptake of [ 3 H]thymidine by the EL-4 target cells to background levels. Mice inoculated intraperitoneally with EL-4 cells were cured of their ascites after intraperitoneal injection of 150 microcuries of the antigen-specific radioimmunoconjugate, suggesting a possible role for such conjugates in intracavitary cancer therapy.
10
Robert W. Kozak, Robert W. Atcher, Otto A. Gansow et al. · Proceedings of the National Academy of Sciences · 1986 · 198 citations · Full text
Medicine, Nuclear Medicine, Oncology +16
Astatine-211—Tellurium Radiocolloid Cures Experimental Malignant Ascites
William D. Bloomer, William McLaughlin, R.D. Neirinckx et al. · Science · 1981 · 88 citations
Medicine, Oncology, Pharmacology +15